αPD-1-Conjugated Acid-Cleavable Nanodrugs Overcomes Cellular Immunotherapy Barriers in Pancreatic Tumors

Scientists presented a nanoengineered tumor-infiltrating lymphocyte therapy using anti-PD-1 antibody-conjugated ZIF-8 nanoparticles to effectively suppress pancreatic tumor growth.